Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on Oct 8, 2012
For more info, visit http://www.bio-rad.com/yt/6/proteonxpr36 Clostridium difficile infections are increasing in incidence, severity, and mortality: rapid identification of virulent strains is essential for preventing their spread. In this webinar, Dr Carlotta Chiappa presented how the ProteOn XPR36 system played a key role in screening and selecting specific mAbs for the development of a chemiluminescent immunoassay to detect Clostridium difficile antigens. The flexibility in assay orientation options provided by the ProteOn system allowed multiple analyses on hybridoma supernatants to identify the best candidates in terms of affinity and performance prediction.
Presenter: Carlotta Chiappa, PhD Antibody Development Unit DiaSorin Research Center, Italy
Our mission: To provide useful, high-quality products and services that advance scientific discovery and improve healthcare. At Bio-Rad, we are united behind this effort. These two objectives are the driving force behind every decision we make, from developing innovative ideas to building global solutions that help solve our customers' greatest challenges.